Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Enoch

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Microbiology Spectrum|May 9, 2022
Real-World Financial and Clinical Impact of Diagnostic-Driven and Empirical-Treatment Strategies in High-Risk Immunocompromised Patients with Suspected Aspergillus Infection in the United KingdomStephanie R Earnshaw, Cheryl McDade, Andrew Bryan, et al.
Infectious Diseases and Therapy|May 12, 2023
Using Behavior Change Theory to Identify Drivers and Barriers for Antifungal Treatment Decisions: A Case Study in a Large Teaching Hospital in the East of England, UKChristianne Micallef, Anita H Sung, Maria Gheorghe, et al.
Microbiology Spectrum|August 18, 2022
Erratum for Earnshaw et al., "Real-World Financial and Clinical Impact of Diagnostic-Driven and Empirical-Treatment Strategies in High-Risk Immunocompromised Patients with Suspected Aspergillus Infection in the United Kingdom"Stephanie R Earnshaw, Cheryl McDade, Andrew Bryan, et al.
The Lancet Regional Health. Europe|June 26, 2021
Diagnostic tool or screening programme? Asymptomatic testing for SARS-CoV-2 needs clear goals and protocolsJordan P Skittrall, Mary D Fortune, Hamid Jalal, et al.
Microbial Genomics|July 5, 2023
Long-read sequencing reveals genomic diversity and associated plasmid movement of carbapenemase-producing bacteria in a UK hospital over 6 yearsLeah W Roberts, David A Enoch, Fahad Khokhar, et al.
The Journal of Antimicrobial Chemotherapy|March 8, 2018
Treatment of infections caused by multidrug-resistant Gram-negative bacteria: report of the British Society for Antimicrobial Chemotherapy/Healthcare Infection Society/British Infection Association Joint Working PartyPeter M Hawkey, Roderic E Warren, David M Livermore, et al.
Journal of Medical Microbiology|April 17, 2026
Use of TaqMan array card to investigate bacterial isolates in diabetic foot ulcersSarah Johnson-Lynn, Martin D Curran, Candice Allen, et al.
BMJ Open|March 4, 2019
Adherence to antibiotic guidelines and reported penicillin allergy: pooled cohort data on prescribing and allergy documentation from two English National Health Service (NHS) trustsCameron J Phillips, Mark Gilchrist, Fiona J Cooke, et al.
Mycoses|June 16, 2021
Reimbursement of innovative pharmaceuticals in English and Spanish hospitals-The example of isavuconazoleJulia Jeck, Sebastian M Wingen-Heimann, Christian Thielscher, et al.
The Journal of Antimicrobial Chemotherapy|September 23, 2016
Patient and public understanding and knowledge of antimicrobial resistance and stewardship in a UK hospital: should public campaigns change focus?Christianne Micallef, Kornelija Kildonaviciute, Enrique Castro-Sánchez, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Microbiology Spectrum|May 9, 2022
Real-World Financial and Clinical Impact of Diagnostic-Driven and Empirical-Treatment Strategies in High-Risk Immunocompromised Patients with Suspected Aspergillus Infection in the United KingdomStephanie R Earnshaw, Cheryl McDade, Andrew Bryan, et al.
Infectious Diseases and Therapy|May 12, 2023
Using Behavior Change Theory to Identify Drivers and Barriers for Antifungal Treatment Decisions: A Case Study in a Large Teaching Hospital in the East of England, UKChristianne Micallef, Anita H Sung, Maria Gheorghe, et al.
Microbiology Spectrum|August 18, 2022
Erratum for Earnshaw et al., "Real-World Financial and Clinical Impact of Diagnostic-Driven and Empirical-Treatment Strategies in High-Risk Immunocompromised Patients with Suspected Aspergillus Infection in the United Kingdom"Stephanie R Earnshaw, Cheryl McDade, Andrew Bryan, et al.
The Lancet Regional Health. Europe|June 26, 2021
Diagnostic tool or screening programme? Asymptomatic testing for SARS-CoV-2 needs clear goals and protocolsJordan P Skittrall, Mary D Fortune, Hamid Jalal, et al.
Microbial Genomics|July 5, 2023
Long-read sequencing reveals genomic diversity and associated plasmid movement of carbapenemase-producing bacteria in a UK hospital over 6 yearsLeah W Roberts, David A Enoch, Fahad Khokhar, et al.
The Journal of Antimicrobial Chemotherapy|March 8, 2018
Treatment of infections caused by multidrug-resistant Gram-negative bacteria: report of the British Society for Antimicrobial Chemotherapy/Healthcare Infection Society/British Infection Association Joint Working PartyPeter M Hawkey, Roderic E Warren, David M Livermore, et al.
Journal of Medical Microbiology|April 17, 2026
Use of TaqMan array card to investigate bacterial isolates in diabetic foot ulcersSarah Johnson-Lynn, Martin D Curran, Candice Allen, et al.
BMJ Open|March 4, 2019
Adherence to antibiotic guidelines and reported penicillin allergy: pooled cohort data on prescribing and allergy documentation from two English National Health Service (NHS) trustsCameron J Phillips, Mark Gilchrist, Fiona J Cooke, et al.
Mycoses|June 16, 2021
Reimbursement of innovative pharmaceuticals in English and Spanish hospitals-The example of isavuconazoleJulia Jeck, Sebastian M Wingen-Heimann, Christian Thielscher, et al.
The Journal of Antimicrobial Chemotherapy|September 23, 2016
Patient and public understanding and knowledge of antimicrobial resistance and stewardship in a UK hospital: should public campaigns change focus?Christianne Micallef, Kornelija Kildonaviciute, Enrique Castro-Sánchez, et al.
Pageof 5